18-657352-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000701410.1(TYMSOS):​n.245A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 173,424 control chromosomes in the GnomAD database, including 40,665 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 34942 hom., cov: 31)
Exomes 𝑓: 0.73 ( 5723 hom. )

Consequence

TYMSOS
ENST00000701410.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.883

Publications

30 publications found
Variant links:
Genes affected
TYMSOS (HGNC:29553): (TYMS opposite strand RNA)
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000701410.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.714 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000701410.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
NR_171001.1
n.450+490A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
ENST00000323813.6
TSL:1
n.511+490A>G
intron
N/A
TYMSOS
ENST00000701410.1
n.245A>G
non_coding_transcript_exon
Exon 1 of 2
TYMSOS
ENST00000585033.1
TSL:2
n.428+490A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
102856
AN:
151908
Hom.:
34908
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.631
Gnomad AMI
AF:
0.790
Gnomad AMR
AF:
0.726
Gnomad ASJ
AF:
0.694
Gnomad EAS
AF:
0.474
Gnomad SAS
AF:
0.635
Gnomad FIN
AF:
0.731
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.702
Gnomad OTH
AF:
0.676
GnomAD4 exome
AF:
0.729
AC:
15596
AN:
21396
Hom.:
5723
AF XY:
0.730
AC XY:
7923
AN XY:
10848
show subpopulations
African (AFR)
AF:
0.659
AC:
511
AN:
776
American (AMR)
AF:
0.759
AC:
419
AN:
552
Ashkenazi Jewish (ASJ)
AF:
0.757
AC:
689
AN:
910
East Asian (EAS)
AF:
0.509
AC:
510
AN:
1002
South Asian (SAS)
AF:
0.741
AC:
160
AN:
216
European-Finnish (FIN)
AF:
0.780
AC:
1367
AN:
1752
Middle Eastern (MID)
AF:
0.725
AC:
87
AN:
120
European-Non Finnish (NFE)
AF:
0.739
AC:
10761
AN:
14564
Other (OTH)
AF:
0.726
AC:
1092
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
208
416
624
832
1040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.677
AC:
102945
AN:
152028
Hom.:
34942
Cov.:
31
AF XY:
0.679
AC XY:
50431
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.631
AC:
26168
AN:
41450
American (AMR)
AF:
0.726
AC:
11093
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.694
AC:
2408
AN:
3472
East Asian (EAS)
AF:
0.475
AC:
2443
AN:
5148
South Asian (SAS)
AF:
0.635
AC:
3059
AN:
4820
European-Finnish (FIN)
AF:
0.731
AC:
7734
AN:
10576
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.702
AC:
47717
AN:
67960
Other (OTH)
AF:
0.671
AC:
1418
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1722
3444
5165
6887
8609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.687
Hom.:
126463
Bravo
AF:
0.673
Asia WGS
AF:
0.544
AC:
1891
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.0
DANN
Benign
0.59
PhyloP100
0.88
PromoterAI
0.016
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2853741;
hg19: chr18-657352;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.